No Data
No Data
Kyorin Pharmaceutical Secures Exclusive License for Bayer's Novel OSA Treatment
Volume change rate ranking (10:00) - FISCO, Taiseioton, etc. ranked in.
In the volume change rate ranking, by comparing the average volume of the last 5 days with the volume on the day of distribution, it is possible to understand the trends of market participants' interests, etc. ■ Top volume change rates [As of December 9, 10:32] (Comparison with the average volume of the last 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <3807> Fisco 16968500 224898.825 8.43% 0.3709% <1904> Taisei
Kyorin Pharmaceutical: Confirmation letter
Kyorin Pharmaceutical: Interim Report - 67th term (2024/04/01 - 2025/03/31)
SASMED --- 1Q sales slightly decreased, revenue from DTx platform business is stable.
Susmed <4263> announced its first quarter results for the fiscal year ending June 2025 (July-September 24). Operating income decreased by 1.4% year-on-year to 0.032 billion yen, operating loss was 0.161 billion yen (compared to a loss of 0.15 billion yen in the same period last year), ordinary loss was 0.163 billion yen (compared to a loss of 0.145 billion yen), and quarterly net loss was 0.163 billion yen (compared to a loss of 0.146 billion yen). There was no recognition of operating income for the DTx product business segment (same as the previous year's same period), and the segment loss was 0.04 billion yen (compared to the same period last year).
Nissan revised its operating profit downwards to 150 billion yen from 500 billion yen on March 25th.
Nissan <7201> announced a revision to its 2025 fiscal year financial estimates. The operating profit was revised downward from 500 billion yen to 150 billion yen. The assumed exchange rate was revised to 1 dollar = 149 yen (previously 1 dollar = 155 yen), and 1 euro = 164 yen (previously 1 euro = 167 yen). The global passengers carried is set at 3.4 million units, down from the previous estimate of 3.65 million units. It was also announced that they will sell some of the shareholding in Mitsubishi Motors <7211>. [Positive Assessment] <5801> Furukawa Electric midterm | <674